The authors also analysed IL‐1β transcript levels on other SS skin specimens and found increased expression only in 3 out of 7 samples, thus endorsing the hypothesis that increased IL‐1β signalling may exist in a subgroup and not in all SS patients. The gene discussed is IL1B; the disease is synovial sarcoma.